5-Methylpsilocybin
Pharmaceutical compound
From Wikipedia, the free encyclopedia
5-Methylpsilocybin is a psychedelic drug, a synthetic analogue of psilocybin, which has high serotonergic activity.[1][2][3] It produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.[1]
Other names5-Methyl-4-phosphoryloxy-N,N-dimethyltryptamine; 5-Me-4-PO-DMT
Drug classSerotonergic psychedelic; Hallucinogen; Serotonin receptor agonist; Serotonin 5-HT2A receptor agonist
ATC code
- None
Legal status
- Generally not controlled
| Clinical data | |
|---|---|
| Other names | 5-Methyl-4-phosphoryloxy-N,N-dimethyltryptamine; 5-Me-4-PO-DMT |
| Drug class | Serotonergic psychedelic; Hallucinogen; Serotonin receptor agonist; Serotonin 5-HT2A receptor agonist |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C13H19N2O4P |
| Molar mass | 298.279 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Chemistry
Synthesis
5-Methylpsilocybin can be synthesized by enzymatic phosphorylation of its synthetic precursor, 5-methylpsilocin, using the enzyme 4-hydroxytryptamine kinase purified from Psilocybe cubensis.[1][2]